1 / 11

Regulation of Chemo Wastes Under RCRA

Regulation of Chemo Wastes Under RCRA. John Gorman EPA Region 2 212-637-4008 gorman.john@epa.gov. RCRA Regulated Chemotherapy Wastes. Eight are U-listed: Chlorambucil (Leukeran) (U035) Cyclophosphamide (Cytoxan, CTX, Neosar, Procytox) (U058)

miranda
Download Presentation

Regulation of Chemo Wastes Under RCRA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Regulation of Chemo Wastes Under RCRA John Gorman EPA Region 2 212-637-4008 gorman.john@epa.gov

  2. RCRA Regulated Chemotherapy Wastes • Eight are U-listed: • Chlorambucil (Leukeran) (U035) • Cyclophosphamide (Cytoxan, CTX, Neosar, Procytox) (U058) • Daunomycin (Daunorubicin, Cerubidine, DaunoXome, Rubidomycin, Liposomal Daunorubicin) (U059) • Diethylstilbestrol (Diethylstilbesterol, DES, Stilbestrol, Honvol, Stilbesterol)(U089) • Melphalan (Alkeran, L-PAM) (U150) • Mitomycin C (Mitomycin, Mutamycin) (U010) • Streptozotocin (Streptozocin, Zanosar) (U206) • Uracil Mustard (U237) EPA Region 2 Healthcare Compliance Initiative

  3. RCRA Regulated Chemotherapy Wastes • One is P-listed: • Arsenic Trioxide (Trisenox) (P012) EPA Region 2 Healthcare Compliance Initiative

  4. Chemotherapy Wastes (Cont’d) • Other listed chemicals used in cancer research or treatment; but not FDA approved: • Azaserine (U015) • Chlornaphazin (U026) • Ethyl Carbamate (U238) • 3-Methylcholanthrene (U157) EPA Region 2 Healthcare Compliance Initiative

  5. Bulk & Trace Chemo • These terms do not exist in the federal regulatory program • Mixture rule applies to listed chemo wastes (see 40 CFR §261.3(a)(2)(iv)) • No minimum quantity or concentration to exit regulatory system EPA Region 2 Healthcare Compliance Initiative

  6. Mixture Rule • A solid waste is a hazardous waste if: • It is a mixture of a solid waste and a hazardous waste not listed solely because it exhibits a characteristic EPA Region 2 Healthcare Compliance Initiative

  7. Practical Application to PPE • HW only if contaminated with listed chemo wastes • Solid waste if uncontaminated • Signs of contamination include: shiny sheen, change in color, change in texture or feel of the PPE, or seeing the material on the PPE • Note: NIOSH & OSHA recommend handling all PPE as contaminated EPA Region 2 Healthcare Compliance Initiative

  8. Management of Containers • Containers may also be regulated • If the container is not “empty” and • if they formerly held a hazardous waste • Different rules for P-listed and U-listed wastes EPA Region 2 Healthcare Compliance Initiative

  9. Empty Containers – U-Listed Wastes (40 CFR §261.7) • Containers, IV bags, vials and inner liners that have held U-listed hazardous waste are deemed empty when: • All the wastes have been removed that can be removed, and • No more than one inch of residue remains on the bottom of the container or inner liner, or • No more than 3 percent by weight of the total capacity of the container remains in the container or inner liner if the container is less than or equal to 110 gallons in size. • Any residues removed from the container are managed as listed HW. EPA Region 2 Healthcare Compliance Initiative

  10. P-Listed Wastes • Not subject to the empty container rule • Containers, IV bags, vials and inner liners that have held P-listed hazardous waste are a HW unless triple rinsed with an appropriate solvent • The rinse water must be managed as a hazardous waste. EPA Region 2 Healthcare Compliance Initiative

  11. Best Management Practices • Handle all chemo wastes as HW • Reverse distribution • Pharmacy as accumulation area • Special marking on regulated chemo containers • Develop standard policy for PPE EPA Region 2 Healthcare Compliance Initiative

More Related